Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary shares, no par value per share
-
Shares outstanding
-
2,006,543,493
-
Total 13F shares
-
80,346
-
Share change
-
-92,106
-
Total reported value
-
$376,821
-
Price per share
-
$4.69
-
Number of holders
-
12
-
Value change
-
-$567,896
-
Number of buys
-
5
-
Number of sells
-
4
Institutional Holders of PURPLE BIOTECH LTD. - Ordinary shares, no par value per share (PPBT) as of Q4 2024
As of 31 Dec 2024,
PURPLE BIOTECH LTD. - Ordinary shares, no par value per share (PPBT) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
80,346 shares.
The largest 10 holders included
KINGSWOOD WEALTH ADVISORS, LLC, TWO SIGMA SECURITIES, LLC, UBS Group AG, GROUP ONE TRADING LLC, BNP PARIBAS FINANCIAL MARKETS, MORGAN STANLEY, RHUMBLINE ADVISERS, CROWLEY WEALTH MANAGEMENT, INC., Tower Research Capital LLC (TRC), and TD Waterhouse Canada Inc..
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.